Liqin Deng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Liqin Deng has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Lu Wang
Department of Anesthesiology and Perioperative Medicine, General Hospital of Ningxia Medical University
7 shared publicationsYanan Wu
Department of Anesthesiology and Perioperative Medicine, General Hospital of Ningxia Medicine University, Yinchuan, China
5 shared publicationsJunyang Ma
Department of Anesthesiology and Perioperative Medicine, General Hospital of Ningxia Medicine University, Yinchuan, China
4 shared publicationsXiaoxia Tian
Department of Anesthesiology and Perioperative Medicine, General Hospital of Ningxia Medicine University, Yinchuan, China
4 shared publicationsJing Cheng
Department of Anesthesiology, Maternal and Child Health Hospital of Hubei Province, No. 745 Wuluo Street, Hongshan District, Wuhan 430070, Hubei, China
3 shared publications- Junyang Ma
Department of Anesthesiology, Maternal and Child Health Hospital of Hubei Province, No.745 Wuluo Street, Hongshan District, Wuhan 430070, Hubei, China
3 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Disease-specific cognitive impacts in aging: a large-scale longitudinal analysis of chronic conditions and demographic modifiers
- 28 July 2026
- Published by Springer Nature in BMC Public Health
- Vol. 26 (1)
Open AccessDisease-specific cognitive impacts in aging: a large-scale longitudinal analysis of chronic conditions and demographic modifiers
- 25 July 2026
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Cardiometabolic Multimorbidity and Depressive Symptom Trajectories in middle-aged and older adults with Chronic Pain: Evidence from the CHARLS and ELSA Cohorts
Introduction: The co-occurrence of chronic pain and cardiometabolic multimorbidity (CMM) is increasingly prevalent among middle-aged and older adults, yet the extent to which CMM shapes the longitudinal course of depressive symptomatology in this population remains poorly understood. Material and methods: Data were drawn from the China Health and Retirement Longitudinal Study (CHARLS; participants aged 45 years and older) and the English Longitudinal Study of Ageing (ELSA; participants aged 50 years and older). Group-based trajectory modeling (GBTM) was applied to identify distinct depressive symptom trajectories, and multinomial logistic regression was used to examine associations between CMM and trajectory group membership, with subgroup analyses conducted to assess potential effect modification. Results: Three stable depressive symptom trajectories were identified in both cohorts: persistently low-, moderate-, and high-symptom groups. In ELSA, CMM was significantly associated with both moderate- (OR: 1.56, 95% CI: 1.24–1.96) and high-symptom trajectories (OR: 2.20, 95% CI: 1.61–3.02) after full covariate adjustment. In CHARLS, the association was confined to the high-symptom trajectory (OR: 1.39, 95% CI: 1.03–1.86). Subgroup analyses indicated a more pronounced association among female participants in CHARLS and among those younger than 65 years in ELSA. Conclusions: CMM is significantly associated with more severe depressive symptom trajectories among middle-aged and older adults with chronic pain, with cross-cohort heterogeneity reflecting differences in population characteristics and sociocultural context. Systematic CMM screening within chronic pain management may help identify individuals at elevated risk for adverse psychological outcomes.
- 25 July 2026
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
Cardiometabolic Multimorbidity and Depressive Symptom Trajectories in middle-aged and older adults with Chronic Pain: Evidence from the CHARLS and ELSA Cohorts
Introduction: The co-occurrence of chronic pain and cardiometabolic multimorbidity (CMM) is increasingly prevalent among middle-aged and older adults, yet the extent to which CMM shapes the longitudinal course of depressive symptomatology in this population remains poorly understood. Material and methods: Data were drawn from the China Health and Retirement Longitudinal Study (CHARLS; participants aged 45 years and older) and the English Longitudinal Study of Ageing (ELSA; participants aged 50 years and older). Group-based trajectory modeling (GBTM) was applied to identify distinct depressive symptom trajectories, and multinomial logistic regression was used to examine associations between CMM and trajectory group membership, with subgroup analyses conducted to assess potential effect modification. Results: Three stable depressive symptom trajectories were identified in both cohorts: persistently low-, moderate-, and high-symptom groups. In ELSA, CMM was significantly associated with both moderate- (OR: 1.56, 95% CI: 1.24–1.96) and high-symptom trajectories (OR: 2.20, 95% CI: 1.61–3.02) after full covariate adjustment. In CHARLS, the association was confined to the high-symptom trajectory (OR: 1.39, 95% CI: 1.03–1.86). Subgroup analyses indicated a more pronounced association among female participants in CHARLS and among those younger than 65 years in ELSA. Conclusions: CMM is significantly associated with more severe depressive symptom trajectories among middle-aged and older adults with chronic pain, with cross-cohort heterogeneity reflecting differences in population characteristics and sociocultural context. Systematic CMM screening within chronic pain management may help identify individuals at elevated risk for adverse psychological outcomes.
- Open Access
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1854727
Nutritional risk score drives postoperative morbidity in colorectal cancer: findings from a LASSO-selected multivariable model in 1013 consecutive patients
Background: Postoperative complications afflict approximately 40% of patients undergoing colorectal cancer (CRC) surgery and adversely affect long-term oncological outcomes. Reliable perioperative risk stratification tools that are both clinically interpretable and actionable remain limited. Methods: This retrospective cohort study enrolled 1,013 consecutive patients undergoing elective radical resection for histopathologically confirmed CRC at a single tertiary center. A nine-system composite complication endpoint was defined. Missing data were handled via multiple imputation by chained equations (MICE; m = 5). Candidate predictors were screened by univariable logistic regression and LASSO regularization; final predictors were entered into multivariable logistic regression with Rubin’s rules pooling. Model performance was assessed by AUC, bootstrap internal validation (1,000 iterations), Hosmer–Lemeshow calibration, and decision curve analysis (DCA). A nomogram was constructed for individualized risk estimation. Results: Of 1,013 patients, 372 (36.7%) experienced ≥1 postoperative complication. LASSO selected eight independent predictors: NRS-2002 nutritional risk score (aOR 1.502, 95% CI 1.312–1.720), laparoscopic approach (aOR 0.457, 95% CI 0.297–0.702), intraoperative blood loss (aOR 1.002/mL), right colon tumor location (aOR 1.502), NLR (aOR 1.080/unit), operative time (aOR 1.002/min), hemoglobin, and total bilirubin. The model achieved an apparent AUC of 0.689 (bootstrap-corrected 0.680), satisfactory calibration (Hosmer–Lemeshow p = 0.709), and net clinical benefit across threshold probabilities of 10–90% on DCA. Sensitivity analyses confirmed robustness across four pre-specified scenarios (AUC range 0.666–0.715). Conclusion: This LASSO-derived nomogram provides transparent, bedside-applicable risk stratification for postoperative composite complications in CRC surgery, identifying nutritional status as the dominant modifiable predictor and supporting targeted perioperative optimization.
- 22 July 2026
- Published by Frontiers Media SA in Frontiers in Nutrition
- Vol. 13, 1854727
Open AccessNutritional risk score drives postoperative morbidity in colorectal cancer: findings from a LASSO-selected multivariable model in 1013 consecutive patients
Background: Postoperative complications afflict approximately 40% of patients undergoing colorectal cancer (CRC) surgery and adversely affect long-term oncological outcomes. Reliable perioperative risk stratification tools that are both clinically interpretable and actionable remain limited. Methods: This retrospective cohort study enrolled 1,013 consecutive patients undergoing elective radical resection for histopathologically confirmed CRC at a single tertiary center. A nine-system composite complication endpoint was defined. Missing data were handled via multiple imputation by chained equations (MICE; m = 5). Candidate predictors were screened by univariable logistic regression and LASSO regularization; final predictors were entered into multivariable logistic regression with Rubin’s rules pooling. Model performance was assessed by AUC, bootstrap internal validation (1,000 iterations), Hosmer–Lemeshow calibration, and decision curve analysis (DCA). A nomogram was constructed for individualized risk estimation. Results: Of 1,013 patients, 372 (36.7%) experienced ≥1 postoperative complication. LASSO selected eight independent predictors: NRS-2002 nutritional risk score (aOR 1.502, 95% CI 1.312–1.720), laparoscopic approach (aOR 0.457, 95% CI 0.297–0.702), intraoperative blood loss (aOR 1.002/mL), right colon tumor location (aOR 1.502), NLR (aOR 1.080/unit), operative time (aOR 1.002/min), hemoglobin, and total bilirubin. The model achieved an apparent AUC of 0.689 (bootstrap-corrected 0.680), satisfactory calibration (Hosmer–Lemeshow p = 0.709), and net clinical benefit across threshold probabilities of 10–90% on DCA. Sensitivity analyses confirmed robustness across four pre-specified scenarios (AUC range 0.666–0.715). Conclusion: This LASSO-derived nomogram provides transparent, bedside-applicable risk stratification for postoperative composite complications in CRC surgery, identifying nutritional status as the dominant modifiable predictor and supporting targeted perioperative optimization.
- Open Access
- 13 July 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1864078
Preoperative and early postoperative albumin thresholds, rather than ΔAlb, predict severe complications after colorectal cancer surgery: a multifactorial model and nomogram
Background: Postoperative complications of colorectal cancer significantly impact prognosis and healthcare burdens. While the dynamic change from preoperative to the lowest albumin level on postoperative day 2 (ΔAlb) has been linked to complications, their predictive value remains controversial. This study aims to explore the relationship between ΔAlb and postoperative complications, and evaluates a multifactorial predictive model for severe complications. Methods: This retrospective study analyzed 932 patients undergoing colorectal cancer resection (August 2020–April 2022). Data included preoperative/postoperative albumin levels, demographics, surgical/anesthetic details, and 30-day complications. ΔAlb’s association with severe complications was assessed via logistic regression, and a nomogram was developed. Results: Severe complications (Clavien–Dindo III–V) occurred in 14.2% of patients. ΔAlb showed no significant association with severe complications in univariate (P = 0.185) or multivariate analysis and discriminated poorly on ROC analysis (AUC 0.536, 95% CI 0.479–0.593). In the final multivariable model using clinically dichotomised predictors, preoperative albumin <35 g/L (OR 2.05, 95% CI 1.29–3.25, P = 0.003) and POD2 nadir albumin 65 years (OR 2.14, P = 0.003), ASA ≥3 (OR 2.14, P = 0.001), preoperative NRS2002 ≥2 (OR 1.97, P = 0.028) and rocuronium dose ≥117.5 mg (OR 4.44, P<0.001). A nomogram integrating these factors showed good discrimination (apparent C-index 0.794; optimism-corrected 0.784 by 1000-sample bootstrapping), good calibration (Hosmer–Lemeshow P = 0.72) and net clinical benefit on decision-curve analysis. Conclusion: ΔAlb alone has limited predictive value, whereas absolute preoperative albumin <35 g/L and POD2 nadir albumin <28.5 g/L are independent predictors of severe complications. A multifactorial model integrating these absolute albumin thresholds with age, ASA score, preoperative NRS2002 and rocuronium dose improves prediction (optimism-corrected C-index 0.78) compared with individual factors (AUC <0.7). Because rocuronium dose may also reflect surgical complexity and perioperative management, these associations require prospective, multicentre validation.
- 13 July 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1864078
Open AccessPreoperative and early postoperative albumin thresholds, rather than ΔAlb, predict severe complications after colorectal cancer surgery: a multifactorial model and nomogram
Background: Postoperative complications of colorectal cancer significantly impact prognosis and healthcare burdens. While the dynamic change from preoperative to the lowest albumin level on postoperative day 2 (ΔAlb) has been linked to complications, their predictive value remains controversial. This study aims to explore the relationship between ΔAlb and postoperative complications, and evaluates a multifactorial predictive model for severe complications. Methods: This retrospective study analyzed 932 patients undergoing colorectal cancer resection (August 2020–April 2022). Data included preoperative/postoperative albumin levels, demographics, surgical/anesthetic details, and 30-day complications. ΔAlb’s association with severe complications was assessed via logistic regression, and a nomogram was developed. Results: Severe complications (Clavien–Dindo III–V) occurred in 14.2% of patients. ΔAlb showed no significant association with severe complications in univariate (P = 0.185) or multivariate analysis and discriminated poorly on ROC analysis (AUC 0.536, 95% CI 0.479–0.593). In the final multivariable model using clinically dichotomised predictors, preoperative albumin <35 g/L (OR 2.05, 95% CI 1.29–3.25, P = 0.003) and POD2 nadir albumin 65 years (OR 2.14, P = 0.003), ASA ≥3 (OR 2.14, P = 0.001), preoperative NRS2002 ≥2 (OR 1.97, P = 0.028) and rocuronium dose ≥117.5 mg (OR 4.44, P<0.001). A nomogram integrating these factors showed good discrimination (apparent C-index 0.794; optimism-corrected 0.784 by 1000-sample bootstrapping), good calibration (Hosmer–Lemeshow P = 0.72) and net clinical benefit on decision-curve analysis. Conclusion: ΔAlb alone has limited predictive value, whereas absolute preoperative albumin <35 g/L and POD2 nadir albumin <28.5 g/L are independent predictors of severe complications. A multifactorial model integrating these absolute albumin thresholds with age, ASA score, preoperative NRS2002 and rocuronium dose improves prediction (optimism-corrected C-index 0.78) compared with individual factors (AUC <0.7). Because rocuronium dose may also reflect surgical complexity and perioperative management, these associations require prospective, multicentre validation.
- 20 August 2025
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 106, 111975
Response to “The role positioning of AI in clinical decision-making”
- 20 August 2025
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 106, 111975
Response to “The role positioning of AI in clinical decision-making”
- 19 August 2025
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 106, 111974
Response to “overlooked clinical realities in ChatGPT vs. DeepSeek comparative studies: Barriers to translating dynamic decision support to practice”
- 19 August 2025
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 106, 111974
Response to “overlooked clinical realities in ChatGPT vs. DeepSeek comparative studies: Barriers to translating dynamic decision support to practice”
- Open Access
- 6 June 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-10
Clinical value of preoperative oral carbohydrate loading in patients with diabetes: a cross-sectional study
Preoperative oral carbohydrate loading (POCL) has shown benefits in non-diabetic patients, but its use in patients with diabetes remains controversial. Concerns about potential hyperglycemia and adverse outcomes have led to conflicting evidence and varied clinical practices. To assess the impact of POCL on clinical outcomes after surgery in patients with diabetes. This retrospective study analyzed 679 patients with diabetes undergoing elective surgery from 2020 to 2023, divided into POCL and fasting groups. After 1:1 propensity score matching (PSM), 410 patients were analyzed. Primary outcomes included postoperative blood glucose levels; secondary outcomes were including glycemic variability, pulmonary infections, hospital stay length, and costs. After PSM, POCL was associated with significantly lower blood glucose levels on the first postoperative day compared to the fasting group (11.03 [9.43–12.77] vs. 11.37 [9.77–13.20], P = 0.045). No significant differences were observed in glycemic variability. POCL patients demonstrated shorter postoperative hospital stays (5.10 [3.00-7.70] vs. 5.90 [3.80–8.50], P = 0.022). Multivariate analysis revealed that POCL independently predicted reduced hospitalization costs (β=-3417.49, 95% CI [-6358.52, -476.46], P = 0.023) and shorter hospital stays (β=-1.21, 95% CI [-1.83, -0.60], P < 0.001). Higher ASA scores and longer surgical durations were associated with increased costs, while prolonged surgeries correlated with greater pulmonary infection risk (OR = 1.005, 95% CI [1.003–1.008], P < 0.001). Despite previous concerns, POCL appears to be associated with lower early postoperative blood glucose levels, shorter hospital stays, and reduced costs in patients with well-controlled diabetes (HbA1c < 7.5%). It may be a safe and effective perioperative strategy for this specific population, though individualized assessment remains essential.
- 6 June 2025
- Published by Springer Nature in BMC Anesthesiology
- Vol. 25 (1) , 1-10
Open AccessClinical value of preoperative oral carbohydrate loading in patients with diabetes: a cross-sectional study
Preoperative oral carbohydrate loading (POCL) has shown benefits in non-diabetic patients, but its use in patients with diabetes remains controversial. Concerns about potential hyperglycemia and adverse outcomes have led to conflicting evidence and varied clinical practices. To assess the impact of POCL on clinical outcomes after surgery in patients with diabetes. This retrospective study analyzed 679 patients with diabetes undergoing elective surgery from 2020 to 2023, divided into POCL and fasting groups. After 1:1 propensity score matching (PSM), 410 patients were analyzed. Primary outcomes included postoperative blood glucose levels; secondary outcomes were including glycemic variability, pulmonary infections, hospital stay length, and costs. After PSM, POCL was associated with significantly lower blood glucose levels on the first postoperative day compared to the fasting group (11.03 [9.43–12.77] vs. 11.37 [9.77–13.20], P = 0.045). No significant differences were observed in glycemic variability. POCL patients demonstrated shorter postoperative hospital stays (5.10 [3.00-7.70] vs. 5.90 [3.80–8.50], P = 0.022). Multivariate analysis revealed that POCL independently predicted reduced hospitalization costs (β=-3417.49, 95% CI [-6358.52, -476.46], P = 0.023) and shorter hospital stays (β=-1.21, 95% CI [-1.83, -0.60], P < 0.001). Higher ASA scores and longer surgical durations were associated with increased costs, while prolonged surgeries correlated with greater pulmonary infection risk (OR = 1.005, 95% CI [1.003–1.008], P < 0.001). Despite previous concerns, POCL appears to be associated with lower early postoperative blood glucose levels, shorter hospital stays, and reduced costs in patients with well-controlled diabetes (HbA1c < 7.5%). It may be a safe and effective perioperative strategy for this specific population, though individualized assessment remains essential.
- 22 April 2025
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 104, 111839
Comparative analysis of ChatGPT and DeepSeek in dynamic clinical decision-making: A progressive scenario-based evaluation
- 22 April 2025
- Published by Elsevier in Journal of Clinical Anesthesia
- Vol. 104, 111839
Comparative analysis of ChatGPT and DeepSeek in dynamic clinical decision-making: A progressive scenario-based evaluation
- Open Access
- 15 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Effect of ultrasound-guided individualized positive end-expiratory pressure on the severity of postoperative atelectasis in elderly patients: a randomized controlled study
Postoperative pulmonary complications (PPCs) are common in patients undergoing general anesthesia, with atelectasis being a key contributor that increases postoperative mortality and prolongs hospitalization. Our research hypothesis is that ultrasound-guided individualized PEEP titration can reduce postoperative atelectasis. This single-center randomized controlled trial recruited elderly patients for laparoscopic surgery. Patients were randomly assigned to two group: the study group (individualized PEEP groups, PEEP Ind group) and the control group (Fixed PEEP group, PEEP 5 group). All patients in these two groups received volume-controlled ventilation during general anesthesia. Patients in the study group were given ultrasound-guided PEEP, while those in the control group were given a fixed 5 cmH2O PEEP. Bedside ultrasound assessed lung ventilation. The primary outcome was the severity of atelectasis within seven days post-surgery. Eighty-nine patients scheduled for elective laparoscopic radical surgery for colorectal cancer were enrolled in our study. Lung ultrasound scores (LUSs) in the study group during postoperative seven days was significantly decreased compared with that in the control group (P < 0.05). The severity of postoperative atelectasis in the study group was significantly improved. The incidence of PPCs during postoperative 7 days in the study group was significantly less than that in the control group (48.6% vs. 77.8%; RR = 0.625; CI = 0.430–0.909; P = 0.01). In elderly patients undergoing laparoscopic radical resection, lung ultrasound-guided individualized PEEP can alleviate the severity of postoperative atelectasis. Clinical trial number and registry URL: No. ChiCTR2200062979 (https://www.chictr.org.cn).
- 15 November 2024
- Published by Springer Nature in Scientific Reports
- Vol. 14 (1) , 1-12
Open AccessEffect of ultrasound-guided individualized positive end-expiratory pressure on the severity of postoperative atelectasis in elderly patients: a randomized controlled study
Postoperative pulmonary complications (PPCs) are common in patients undergoing general anesthesia, with atelectasis being a key contributor that increases postoperative mortality and prolongs hospitalization. Our research hypothesis is that ultrasound-guided individualized PEEP titration can reduce postoperative atelectasis. This single-center randomized controlled trial recruited elderly patients for laparoscopic surgery. Patients were randomly assigned to two group: the study group (individualized PEEP groups, PEEP Ind group) and the control group (Fixed PEEP group, PEEP 5 group). All patients in these two groups received volume-controlled ventilation during general anesthesia. Patients in the study group were given ultrasound-guided PEEP, while those in the control group were given a fixed 5 cmH2O PEEP. Bedside ultrasound assessed lung ventilation. The primary outcome was the severity of atelectasis within seven days post-surgery. Eighty-nine patients scheduled for elective laparoscopic radical surgery for colorectal cancer were enrolled in our study. Lung ultrasound scores (LUSs) in the study group during postoperative seven days was significantly decreased compared with that in the control group (P < 0.05). The severity of postoperative atelectasis in the study group was significantly improved. The incidence of PPCs during postoperative 7 days in the study group was significantly less than that in the control group (48.6% vs. 77.8%; RR = 0.625; CI = 0.430–0.909; P = 0.01). In elderly patients undergoing laparoscopic radical resection, lung ultrasound-guided individualized PEEP can alleviate the severity of postoperative atelectasis. Clinical trial number and registry URL: No. ChiCTR2200062979 (https://www.chictr.org.cn).
- Open Access
- 1 September 2024
- Published by KEAI Publishing in Journal of Anesthesia and Translational Medicine
- Vol. 3 (3) , 117-122
The effect of perioperative intravenous lidocaine infusion on postoperative sleep of elderly patients with colorectal cancer: A randomized controlled study
Postoperative sleep disturbance (POSD) caused by postoperative pain can impede the enhanced rapid recovery of elderly patients with colorectal cancer. We propose that perioperative intravenous lidocaine infusion may enhance postoperative sleep quality by alleviating postoperative pain in elderly patients undergoing laparoscopic radical resection for colorectal cancer. Sixty-three elderly patients were divided into two groups: the lidocaine group (group L) and the placebo group (group C). Patients in group L received intravenous injection of lidocaine 1.5 mg/kg during the induction of anesthesia, followed by lidocaine 1.0 mg kg−1 h−1 during surgery and for 24 h after surgery. Patients in group C received the same volume of normal saline. The primary outcome was postoperative sleep function, which was evaluated using the Athens Insomnia Scale (AIS). The secondary outcomes included the pain-at-rest and pain-on-movement of patients at 2, 4, 6, 12, 24, 48, and 72 h after surgery, opioid and propofol consumption, bowel function recovery time, postoperative complications, and lidocaine side effects. Compared to group C, AIS scores in group L were significantly lower on day 1 (12.9 ± 4.0 vs 10.6 ± 3.9, P < 0.05), day 3 (8.6 ± 4.2 vs 6.2 ± 3.9, P < 0.05), and 1 week (4.3 ± 3.1 vs 2.2 ± 2.5, P < 0.05) after surgery. There were no significant differences in VAS scores between the two groups. The intraoperative consumption of propofol and remifentanil was significantly reduced in group L. Lidocaine infusion significantly shortened the recovery time of bowel function. There were no statistical differences between the two groups regarding the incidences of PONV and postoperative pulmonary complications. No cases of local anesthetic toxicity occurred in either group. Perioperative intravenous administration of lidocaine can facilitate the restoration of postoperative sleep function in elderly patients undergoing laparoscopic radical resection of colorectal cancer.
- 1 September 2024
- Published by KEAI Publishing in Journal of Anesthesia and Translational Medicine
- Vol. 3 (3) , 117-122
Open AccessThe effect of perioperative intravenous lidocaine infusion on postoperative sleep of elderly patients with colorectal cancer: A randomized controlled study
Postoperative sleep disturbance (POSD) caused by postoperative pain can impede the enhanced rapid recovery of elderly patients with colorectal cancer. We propose that perioperative intravenous lidocaine infusion may enhance postoperative sleep quality by alleviating postoperative pain in elderly patients undergoing laparoscopic radical resection for colorectal cancer. Sixty-three elderly patients were divided into two groups: the lidocaine group (group L) and the placebo group (group C). Patients in group L received intravenous injection of lidocaine 1.5 mg/kg during the induction of anesthesia, followed by lidocaine 1.0 mg kg−1 h−1 during surgery and for 24 h after surgery. Patients in group C received the same volume of normal saline. The primary outcome was postoperative sleep function, which was evaluated using the Athens Insomnia Scale (AIS). The secondary outcomes included the pain-at-rest and pain-on-movement of patients at 2, 4, 6, 12, 24, 48, and 72 h after surgery, opioid and propofol consumption, bowel function recovery time, postoperative complications, and lidocaine side effects. Compared to group C, AIS scores in group L were significantly lower on day 1 (12.9 ± 4.0 vs 10.6 ± 3.9, P < 0.05), day 3 (8.6 ± 4.2 vs 6.2 ± 3.9, P < 0.05), and 1 week (4.3 ± 3.1 vs 2.2 ± 2.5, P < 0.05) after surgery. There were no significant differences in VAS scores between the two groups. The intraoperative consumption of propofol and remifentanil was significantly reduced in group L. Lidocaine infusion significantly shortened the recovery time of bowel function. There were no statistical differences between the two groups regarding the incidences of PONV and postoperative pulmonary complications. No cases of local anesthetic toxicity occurred in either group. Perioperative intravenous administration of lidocaine can facilitate the restoration of postoperative sleep function in elderly patients undergoing laparoscopic radical resection of colorectal cancer.